Technical Analysis for AVCT - Avacta Group Plc

Grade Last Price % Change Price Change
D 116.4 -0.51% -0.60
AVCT closed up 1.04 percent on Wednesday, December 1, 2021, on 71 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical AVCT trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish -0.51%
20 DMA Support Bullish -0.51%
Multiple of Ten Bearish Other -0.51%
Fell Below 50 DMA Bearish 0.52%
20 DMA Support Bullish 0.52%
Multiple of Ten Bearish Other 0.52%
Multiple of Ten Bearish Other -7.62%
Upper Bollinger Band Touch Strength -7.62%
50 DMA Support Bullish -3.00%
Calm After Storm Range Contraction -3.00%
Older End-of-Day Signals for AVCT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2% 20 minutes ago
Fell Below 20 DMA 20 minutes ago
50 DMA Support 41 minutes ago
Rose Above 50 DMA 41 minutes ago
Down 1% about 1 hour ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avacta Group Plc Description

Avacta Group plc is a biotechnology company. Avacta's focus is on its proprietary Affimer technology which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and general research and development. Affimer technology has been designed to address performance limitations of antibodies. Affimer technology is based on a small protein that can be generated to bind with specificity and affinity to a range of targets to enable diagnostics, research assays and therapeutics. Avacta has a pre-clinical therapeutic development programme with an in-house focus on immuno-oncology and bleeding disorders as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Biotechnology Science Medicine Clinic Tools Life Sciences Branches Of Biology Medical Specialties Oncology Immunology Disorders Immune System Assay Antibodies

Is AVCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 291.8
52 Week Low 97.0
Average Volume 1,347,901
200-Day Moving Average 174.69
50-Day Moving Average 117.13
20-Day Moving Average 115.27
10-Day Moving Average 121.18
Average True Range 9.91
ADX 19.71
+DI 22.65
-DI 16.56
Chandelier Exit (Long, 3 ATRs) 108.05
Chandelier Exit (Short, 3 ATRs) 126.83
Upper Bollinger Bands 129.53
Lower Bollinger Band 101.00
Percent B (%b) 0.56
BandWidth 24.75
MACD Line 0.93
MACD Signal Line 0.51
MACD Histogram 0.4211
Fundamentals Value
Market Cap 295.6 Million
Num Shares 253 Million
EPS -11.60
Price-to-Earnings (P/E) Ratio -10.09
Price-to-Sales 31.35
Price-to-Book 4.14
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 130.43
Resistance 3 (R3) 130.60 126.30 128.19
Resistance 2 (R2) 126.30 122.88 126.21 127.44
Resistance 1 (R1) 121.65 120.77 119.50 121.48 126.70
Pivot Point 117.35 117.35 116.28 117.26 117.35
Support 1 (S1) 112.70 113.93 110.55 112.53 107.30
Support 2 (S2) 108.40 111.82 108.31 106.56
Support 3 (S3) 103.75 108.40 105.81
Support 4 (S4) 103.58